After soaring 62% in Q4, the Global Cannabis Stock Index began the new year with a 27.8% gain to 56.71. The index, which had 38 qualifying members during the month following...
After a sharp decline in September that left the index down 7% in Q3, the Global Cannabis Stock Index held on to massive gains in October and November, decreasing 0.8% to...
After a 57.4% gain in Q1, the Global Cannabis Stock Index moved sharply lower again in October, its seventh consecutive monthly decline, as it lost 11.2% to 47.29: The index,...
After a 57.4% gain in Q1 followed by a pullback that had left it down 1% year-to-date as of the end of August, the Global Cannabis Stock Index moved sharply lower...
After a 57.4% gain in Q1 followed by a 28.0% pullback in Q2 and 13.8% decline in July, Cannabis stocks, as measured by the Global Cannabis Stock Index, moved sharply...
After a 57.4% gain in Q1 followed by a 28.0% pullback in Q2, Cannabis stocks, as measured by the Global Cannabis Stock Index, moved sharply lower in July, declining 13.8%:...
This is a copy of the June 9th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, In late May, Governor Polis of Colorado...
Acquisition will add extensive on-shelf product portfolio available in multiple regions Expands PharmaCielo’s global sales reach and market presence in Canada, Switzerland, Europe, Australia, New Zealand, Israel, and Brazil...
PharmaCielo Announces TSX Venture Listing and Provides Corporate Update PharmaCielo to begin trading on the TSX Venture Exchange (“TSXV” or “TSX Venture”) under the Ticker PCLO on or about...
PharmaCielo Closes Subscription Receipt Financings in Two Tranches for Gross Proceeds of over $39 Million; Provides Corporate Update Harvest of ~200,000 CBD-dominant plants and production of cannabis oil extracts...
This is a copy of the April 29th edition of our weekly Newsletter, which we have been publishing since October, 2015. Friends, A few weeks ago, we weighed in...
PharmaCielo and AAJ Announce Private Placement of Subscription Receipts of PharmaCielo for Proceeds of up to $60 Million All financial figures in Canadian Dollars ($) unless otherwise noted TORONTO, April...
PharmaCielo Ltd. to Acquire Colombia’s Leading Provider of Telemedicine Services TORONTO, April 20, 2018 – PharmaCielo Ltd. (the “Company”) announces that it has reached an agreement to acquire Colombia’s...
Two privately-held cannabis companies based in Canada, Khiron Life Sciences and PharmaCielo, are now fully licensed by Colombia to produce low and high THC medical cannabis. Khiron disclosed the news...
Readers of New Cannabis Ventures likely recall how we alerted to the huge opportunities in Canada last June, and the Canadian market continues to evolve as a leader in the...
CannaInsider posted a very timely interview today with PharmaCielo CEO Dr. Patricio Stocker. Just last week, the New York Times profiled the company, suggesting it was set to benefit...
Jim Rogers, who retired from the Quantum Fund, cofounded with George Soros, at age 37 and is well known for his insight into commodity markets, seems pretty bearish these days on...
PharmaCielo, a Canadian company that wholly owns PharmaCielo Colombia Holdings S.A.S, continues to scale up its cannabis operations in Colombia. The company reported today that it has purchased a...
PharmaCielo Receives Manufacturing Licence to Process Cannabis Plants for Medical and Scientific Purposes RIONEGRO, Colombia and TORONTO, Canada, June 28, 2016 /PRNewswire/ – PharmaCielo Colombia Holdings S.A.S, a wholly...
PharmaCielo, a Canadian company with operations in Colombia and a goal to become “the world’s leading supplier of naturally grown and processed, standardized medicinal-grade cannabis oil extracts and related...
